Arcellx, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: ACLX · Form: DEF 14A · Filed: Apr 11, 2024 · CIK: 1786205
| Field | Detail |
|---|---|
| Company | Arcellx, INC. (ACLX) |
| Form Type | DEF 14A |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: Arcellx, ACLX, Annual Meeting, Proxy Statement, Executive Compensation
TL;DR
<b>Arcellx, Inc. invites stockholders to its virtual annual meeting on May 24, 2024, to vote on director elections and executive compensation.</b>
AI Summary
Arcellx, Inc. (ACLX) filed a Proxy Statement (DEF 14A) with the SEC on April 11, 2024. Arcellx, Inc. will hold its annual meeting of stockholders on May 24, 2024, at 9:00 am ET. The meeting will be conducted virtually via live audio webcast at www.proxydocs.com/ACLX. Stockholders will vote on the election of three Class II directors. An advisory vote on the compensation of named executive officers ('Say-on-Pay Vote') will be held. The frequency of future Say-on-Pay Votes will also be subject to an advisory vote.
Why It Matters
For investors and stakeholders tracking Arcellx, Inc., this filing contains several important signals. This filing is a proxy statement, indicating Arcellx is seeking shareholder votes for key corporate governance matters. The virtual format allows broader participation but requires shareholders to actively engage online to vote and submit questions.
Risk Assessment
Risk Level: low — Arcellx, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational disclosures that would indicate significant risk.
Analyst Insight
Stockholders should review the proxy materials to understand the proposals and vote accordingly, particularly on director elections and executive compensation.
Key Numbers
- 3 — Class II directors (To be elected at the annual meeting)
- 2027 — Director term end (Until the 2027 annual meeting of stockholders)
Key Players & Entities
- Arcellx, Inc. (company) — Registrant and filer of the proxy statement
- Rami Elghandour (person) — President, Chief Executive Officer and Chairman of Arcellx, Inc.
- May 24, 2024 (date) — Date of the annual meeting of stockholders
- 9:00 am, ET (time) — Time of the annual meeting of stockholders
- www.proxydocs.com/ACLX (url) — Website for the virtual annual meeting
FAQ
When did Arcellx, Inc. file this DEF 14A?
Arcellx, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 11, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Arcellx, Inc. (ACLX).
Where can I read the original DEF 14A filing from Arcellx, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Arcellx, Inc..
What are the key takeaways from Arcellx, Inc.'s DEF 14A?
Arcellx, Inc. filed this DEF 14A on April 11, 2024. Key takeaways: Arcellx, Inc. will hold its annual meeting of stockholders on May 24, 2024, at 9:00 am ET.. The meeting will be conducted virtually via live audio webcast at www.proxydocs.com/ACLX.. Stockholders will vote on the election of three Class II directors..
Is Arcellx, Inc. a risky investment based on this filing?
Based on this DEF 14A, Arcellx, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational disclosures that would indicate significant risk.
What should investors do after reading Arcellx, Inc.'s DEF 14A?
Stockholders should review the proxy materials to understand the proposals and vote accordingly, particularly on director elections and executive compensation. The overall sentiment from this filing is neutral.
How does Arcellx, Inc. compare to its industry peers?
Arcellx, Inc. operates in the biotechnology sector, focusing on developing cell therapies. This filing pertains to standard corporate governance procedures for publicly traded companies.
Are there regulatory concerns for Arcellx, Inc.?
The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
Risk Factors
- Regulatory Compliance [low — regulatory]: The company must comply with SEC regulations regarding proxy solicitations and corporate governance.
- Virtual Meeting Execution [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is crucial for engagement.
Industry Context
Arcellx, Inc. operates in the biotechnology sector, focusing on developing cell therapies. This filing pertains to standard corporate governance procedures for publicly traded companies.
Regulatory Implications
The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
What Investors Should Do
- Review the proxy statement for details on director nominees and their qualifications.
- Understand the proposals regarding executive compensation and the frequency of advisory votes.
- Vote your shares by the deadline, either online, by phone, or by mail, to ensure your representation at the meeting.
Key Dates
- 2024-05-24: Annual Meeting of Stockholders — Key date for voting on directors and executive compensation.
- 2024-04-11: Filing Date — Date the definitive proxy statement was filed with the SEC.
Year-Over-Year Comparison
This is a definitive proxy statement (DEF 14A) for the 2024 annual meeting, following the typical structure for such filings.
Filing Stats: 4,837 words · 19 min read · ~16 pages · Grade level 12.3 · Accepted 2024-04-11 16:26:28
Filing Documents
- d512281ddef14a.htm (DEF 14A) — 441KB
- g512281dsp047.jpg (GRAPHIC) — 218KB
- g512281dsp048.jpg (GRAPHIC) — 116KB
- g512281g0409054031568.jpg (GRAPHIC) — 4KB
- g512281g0409054031780.jpg (GRAPHIC) — 2KB
- g512281g34a01.jpg (GRAPHIC) — 77KB
- g512281g34a02.jpg (GRAPHIC) — 83KB
- 0001193125-24-093275.txt ( ) — 1131KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 25 Summary Compensation Table for Fiscal 2023 25 Employment Arrangements 25 -iii- Table of Contents Outstanding Equity Awards at Fiscal 2023 Year-End 29 Equity Compensation Plan Information 30
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 35 RELATED PERSON TRANSACTIONS 37 OTHER MATTERS 39 Stockholder Proposals or Director Nominations for 2025 Annual Meeting 39 Availability of Bylaws 39 2023 Annual Report 39 -iv- Table of Contents ARCELLX, INC. PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS To be held at 9:00 am, ET, on Friday, May 24, 2024 The information provided in the question and answer format below is for your convenience only and is merely a summary of the information contained in this proxy statement. You should read this entire proxy statement carefully. QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND OUR ANNUAL MEETING Why am I receiving these materials? This proxy statement and the form of proxy are furnished in connection with the solicitation of proxies by our board of directors for use at the 2024 annual meeting of stockholders of Arcellx, Inc., a Delaware corporation, and any postponements, adjournments or continuations thereof. The annual meeting will be held on Friday, May 24, 2024 at 9:00 am, ET. The annual meeting will be conducted virtually via live audio webcast. You will be able to attend the annual meeting virtually by visiting www.proxydocs.com/ACLX, where you will be able to listen to the meeting live, submit questions and vote online during the meeting. Stockholders can go to www.proxydocs.com/ACLX to register to attend the virtual meeting. Stockholders who register to attend will receive an email containing a link to the virtual meeting one hour prior to the meeting start time. The Notice of Internet Availability of Proxy Materials, or Notice of Internet Availability, containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and form of proxy, and our annual report, is first being sent or given on or about April 11, 2024 to all stockholders of record as of April 1, 2024. The proxy materials and our annual repor